Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer.

Ewen Cummins, Lorna Sharman Aucott, Clare Robertson, Cynthia Fraser, Rhona Johnston, Thomas Lam, Miriam Giovanna Brazzelli

Research output: Book/ReportCommissioned Report

Original languageEnglish
PublisherEvidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health and Care Excellence
Publication statusPublished - 2018

Cite this

Cummins, E., Aucott, L. S., Robertson, C., Fraser, C., Johnston, R., Lam, T., & Brazzelli, M. G. (2018). Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/indevelopment/gid-ta10122